Zhang Long, Zhou Fangfang, van Dinther Maarten, Ten Dijke Peter
Department of Molecular Cell Biology, Cancer Genomics Centre Netherlands and Centre for Biomedical Genetics, Leiden University Medical Center, Postbus 9600 2300 RC, Leiden, The Netherlands.
Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
Methods Mol Biol. 2016;1344:35-47. doi: 10.1007/978-1-4939-2966-5_2.
Transforming growth factor-β (TGF-β) is a pleiotropic cytokine that signals via transmembrane TGF-β type I and type II serine/threonine kinases receptors, i.e., TβRI and TβRII. Upon TGF-β-induced receptor complex formation, the TβRII kinase phosphorylates TβRI. Subsequently, the activated TβRI induces the phosphorylation of receptor regulated SMAD2 and SMAD3, which can form heteromeric complexes with Smad4. These heteromeric SMAD complexes accumulate in the nucleus, where they regulate target gene expression. The stability and membrane localization of TβRI is an important determinant to control the intensity and duration of TGF-β signaling. TβRI is targeted for poly-ubiquitylation-mediated proteasomal degradation by the SMAD7-SMURF E3 ligase complex. We recently identified another important regulatory factor that controls TβRI levels in the cell membrane. As a strong inducer of TGF-β signaling, ubiquitin-specific protease (USP) 4 was found to directly interact with TβRI and act as a deubiquitylating enzyme, thereby stabilizing TβRI levels at the plasma membrane. This chapter introduces methods for examining cell membrane receptor (TβRI) levels.
转化生长因子-β(TGF-β)是一种多效细胞因子,通过跨膜的TGF-β I型和II型丝氨酸/苏氨酸激酶受体(即TβRI和TβRII)进行信号传导。在TGF-β诱导受体复合物形成后,TβRII激酶使TβRI磷酸化。随后,活化的TβRI诱导受体调节型SMAD2和SMAD3磷酸化,它们可与Smad4形成异源复合物。这些异源SMAD复合物在细胞核中积累,在那里它们调节靶基因表达。TβRI的稳定性和膜定位是控制TGF-β信号强度和持续时间的重要决定因素。TβRI被SMAD7-SMURF E3连接酶复合物靶向进行多聚泛素化介导的蛋白酶体降解。我们最近鉴定出另一种控制细胞膜中TβRI水平的重要调节因子。作为TGF-β信号的强诱导剂,泛素特异性蛋白酶(USP)4被发现可直接与TβRI相互作用并作为去泛素化酶,从而稳定质膜上的TβRI水平。本章介绍检测细胞膜受体(TβRI)水平的方法。